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Summary The Scaling-up Health-Arts Programme: Implementation and
Effectiveness Research (SHAPER) project is the world’s largest hybrid study on the
impact of the arts on mental health embedded into a national healthcare system. This
programme, funded by the Wellcome Trust, aims to study the impact and the
scalability of the arts as an intervention for mental health. The programme will be
delivered by a team of clinicians, research scientists, charities, artists, patients and
healthcare professionals in the UK’s National Health Service (NHS) and the
community, spanning academia, the NHS and the charity sector. SHAPER consists of
three studies – Melodies for Mums, Dance for Parkinson’s, and Stroke Odysseys –
which will recruit over 800 participants, deliver the interventions and draw
conclusions on their clinical impact, implementation effectiveness and cost-
effectiveness. We hope that this work will inspire organisations and commissioners
in the NHS and around the world to expand the remit of social prescribing to include
evidence-based arts interventions.
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The field of arts and mental health is a constantly and rap-
idly expanding area of research. We now have numerous
publications, in the UK and globally, suggesting a strong
link between arts-based interventions and improvement in
mental and physical health outcomes.1–9 This invaluable
body of research has shown the clinical effectiveness of the
arts for the treatment of an array of mental and physical
health problems, as diverse as anxiety, depression, cancer,
cerebral palsy and stroke, among others. However, such
research has yet to offer solutions that are readily scalable,
implementable and cost-effective, and that can be employed
in primary and secondary care settings in the National
Health Service (NHS) or equivalent health services in
other countries. Furthermore, these art interventions face
limitations, including the lack of a continuous stream of
funding, limited partnerships with commissioners and fun-
ders, insufficient clinical evidence and difficulties in their
implementation in existing clinical pathways.
The SHAPER project
The Scaling-up Health-Arts Programmes: Implementation
and Effectiveness Research (SHAPER) project aims to start
addressing the above gaps in the evidence base. SHAPER
is a multidisciplinary programme funded by the Wellcome
Trust, and is being run by the Institute of Psychiatry,
Psychology & Neuroscience at King’s College London and
by the Department for Behavioural Science and Health and
the Institute of Mental Health at University College London.
The project aims to scale up three existing community arts
interventions: Melodies for Mums (for women with postnatal
depression), Dance for Parkinson’s, and Stroke Odysseys. These
three interventions have been developed and piloted on a small
scale, offering promising results within their rehabilitation
scopes.10–14
SHAPER was designed following an intensive 6-month
scoping process involving stakeholders at different levels,
including artists, clinicians, patients, researchers and com-
missioners. The aims were to create a programme that
meets specific needs in the healthcare sector, to scale up
interventions that already had promising efficacy pilot data
and to involve high-quality arts interventions led by experi-
enced partners (e.g. Breathe Arts Health Research, the
English National Ballet and Stroke Odysseys). It has the
ambition to be inclusive of the larger patient population
(including those not already engaged in the arts) and,
importantly, to be scalable and commissionable by the
healthcare sector.
The ambition of the programme is thus to embed arts
interventions within a large academic health science centre,
King’s Health Partners (KHP), establishing their delivery in
the medium- to long-term future. As an academic health
sciences centre, KHP’s academic and clinical partners
(King’s College London, Guy’s and St Thomas’ NHS
Foundation Trust, King’s College Hospital NHS Foundation
Trust, and South London and Maudsley NHS Foundation
Trust) bring together research, education and clinical practice
for the benefit of the patients. SHAPER’s objective is to
study the three arts interventions embedded within existing
clinical pathways in order to scale them up to reach larger
numbers of people across KHP and the community, examine
possible mechanisms of efficacy and provide implementation
evidence.
The SHAPER programme intends, ultimately, to enable
clinical commissioning groups (CCGs; i.e. the ‘payers’ in the
NHS) to commission the three interventions, so that they
can continue to be delivered in the future. To attain the
aims mentioned above, three levels of effectiveness must
be assessed: (a) clinical effectiveness, considering the real-
world impact on health outcomes and whether these are
meaningful to clinical practice; (b) implementation effective-
ness, in terms of uptake, suitability, acceptability and feasi-
bility of the interventions; and (c) cost-effectiveness, to
develop strong business plans for commissioners. Since the
interventions selected are at different developmental stages,
an additional ambition of SHAPER is that the implementa-
tion science methodologies developed in this programme
will allow the creation and evaluation of an implementation
model that could be used across future arts interventions,
tailored to different stages of development and delivery.
The adopted research, a three-pronged hybrid type II
effectiveness-implementation evaluation, is the gold standard
of modern implementation science that blends components of
clinical effectiveness and implementation research.15 This
strategy will allow the research team to simultaneously test
the clinical intervention and the implementation strategy,
and our team has used it successfully in previous scale-up
research at King’s College London.15,16
The programme is in the process of obtaining ethics com-
mittee approvals. Consent will be sought from all research
participants and stakeholders involved in these studies.
Cross-cutting implementation and health
economics evaluation
An innovative aspect of the SHAPER programme is that, in
addition to the clinical effectiveness of the interventions,
a systematic approach will be taken to simultaneously
evaluate their implementation effectiveness and cost-
effectiveness. Implementation effectiveness refers to the
uptake, suitability, acceptability and feasibility of the inter-
ventions. This will help us to identify not just ‘if’, but also
‘why’ and ‘how’ the interventions work and for whom, and
will support our understanding of how they can be success-
fully delivered within clinical pathways. This approach of
simultaneously assessing clinical, implementation and cost-
effectiveness of an intervention is supported by the recently
emerged ‘hybrid’ research designs – which offer a framework
for these different elements of effectiveness to be assessed in
parallel.15 Overall, the SHAPER programme is conceptua-
lised as a hybrid type II design, in which the clinical and
implementation effectiveness are given equal weight in the
design of the evaluation across the three focal interventions.
The evaluation of how the interventions are imple-
mented within clinical pathways will further capture bar-
riers and drivers of implementation as well as unintended
consequences for patients and providers. Existing imple-
mentation theory and direct work with a wide group of
stakeholders of the interventions (including patients, arts
and clinical providers) will inform the implementation
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evaluation throughout the programme.17,18 Along similar
lines, the cost-effectiveness evaluation will cover health eco-
nomic evaluations of the implementation and delivery costs
and associated savings, service utilisation and related ana-
lyses. Implementation and cost data will be captured
through a mixed-methods approach comprising a variety of
qualitative and quantitative data collection techniques,
including structured interviews and psychometrically estab-
lished measurement scales.19
In bringing these three studies together, the SHAPER
programme aims to bridge the gap between small-scale
arts interventions and their large-scale implementation
into pathways within the NHS for improved physical and
mental health in people with postnatal depression,
Parkinson’s disease and stroke.
Here, we offer an overview of the three interventions
and of the implementation and cost-effectiveness evaluation
adopted within SHAPER.
Melodies for Mums (arts partner: Breathe Arts
Health Research)
Postnatal depression affects at least 12.9% of new mothers,
with symptoms including fatigue, anhedonia, insomnia
and irritability.20,21 However, challenges surround the fact
that there is still no complete treatment solution: although
pharmacological treatments have had positive results,
these are hampered by low uptake and adherence among
mothers.22–24 Psychotherapy has also produced mixed
results, as well as similar challenges regarding low uptake
or delayed treatment.21,25–27 However, many mothers engage
in community group activities with their babies, such as
attending mother–infant play groups. These activities have
been identified as ways of relaxing mothers, providing good
sources of social interaction, decreasing the monotony of
each day and providing a sense of personal fulfilment.28
Moreover, there is a growing body of evidence demon-
strating the effects of community group singing on mental
health.29,30 Singing to new babies is practised in cultures
around the world, and research has demonstrated valuable
benefits, such as improving mother–infant interaction and
reducing distress in babies.31–33 Listening to music during
pregnancy is also associated with higher levels of well-being
and reduced symptoms of postnatal depression in the first 3
months post-birth, while daily singing to babies is associated
with fewer symptoms of postnatal depression and higher
levels of well-being, self-esteem and perceived mother–
infant bond.10 Consequently, there is a strong theoretical
background indicating that singing could support mothers
with postnatal depression.
Breathe Arts Health Research’s Melodies for Mums
offers free, community-based singing sessions to women
with symptoms of postnatal depression in London boroughs
(Fig. 1). A previous study led by researchers in the SHAPER
team has shown that this intervention, already implemented
in some London boroughs, results in faster improvements in
symptoms when compared with usual care.11 Specifically, the
study recruited 134 women with symptoms of postnatal
depression and found that, in women with moderate to
severe depression, there was significantly faster
improvement in symptoms in the singing group than in
the group play workshops for mothers and babies.
The planned two-arm randomised clinical trial
(SHAPER-PND) aims to establish effectiveness in a larger
sample (400 participants) and to analyse the factors affecting
economic and implementation potentials for this interven-
tion. Participants will be assigned to either a 10-week singing
intervention or a 10-week active waiting-list control
group, where they will be encouraged to attend community
mother–baby activities. Singing sessions will be delivered in
children’s or community centres and each group will have
8–12 mothers and their babies. Mothers and their babies
will be invited to sit in a circle and learn songs from all over
the world, from vocal ‘motherese’ style noises to lullabies
andmore complex songs. They will be invited to hug or stroke
their babies while singing and to add simple musical instru-
ments (maracas, drums, hand chimes and others) to increase
mother–baby interactions. Mothers will also be invited to
develop their own songs about motherhood and their babies,
creating a shared experience with other participants, thereby
increasing their sense of inclusion.
A package of demographic, mental health, biological and
social measures will be collected from mothers and babies at
set time points throughout the intervention, and up to 36
weeks post-randomisation. In addition to the clinical effect-
iveness outcome (an improvement in depressive symptom
score according to the Edinburgh Postnatal Depression
Scale), we will put equal weight on the implementation sci-
ence and economic data assessments. For biological out-
comes, we will collect saliva and hair samples to assess
stress and hormonal markers, including cortisol, oxytocin
and cytokines. We will also conduct qualitative interviews
with a subgroup of mothers who self-report particular risk
factors for postnatal depression, to explore how singing
interacts with specific contexts.
Dance for Parkinson’s (arts partner: English
National Ballet)
Parkinson’s disease is a chronic neurodegenerative condition
affecting over 145 000 people in the UK alone, with a
prevalence expected to rise by around 18% between 2018
and 2025, to over 168 000, and to double by 2065.34
Parkinson’s disease is a complex disorder characterised
by a range of motor symptoms, including slowness of
movement (bradykinesia), tremor and gait impairment, and
non-motor symptoms such as anxiety, depression, sleep dys-
function, autonomic problems, mood disturbances and cogni-
tive decline, with a profound negative effect on quality of
life.35 Although there are no treatments that can affect the
progression of this condition, evidence is emerging that phys-
ical activity and certain types of exercise, including a range of
dance-based exercise, can improve motor symptoms, func-
tional mobility and stability, and result in some cognitive
improvements, reduced pain, depression and anxiety,
decreased social isolation and improved quality of life.36–38
Dance for Parkinson’s is an existing programme deliv-
ered by the English National Ballet (ENB) for people with
Parkinson’s disease (Fig. 2) across multiple venues in the
UK, including London, Ipswich, Cardiff, Liverpool and
34
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Fig. 1 Melodies for Mums session delivered by Breathe Arts Health Research. Image credit: Richard Eaton.
Fig. 2 Dance for Parkinson’s session delivered by the English National Ballet. Image credit: Laurent Liotardo.
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Oxford. The sessions are being delivered by ENB-trained
dance artists and currently host people with Parkinson’s
and carers. These sessions are popular and lend themselves
to the requirement of a large-scale randomised study so as to
provide robust evidence of dance being accepted as a poten-
tial therapeutic option in the pathway of care for Parkinson’s
disease.
As part of the SHAPER project, the study will be sup-
ported by the Wellcome Trust and will take place at the
internationally renowned Parkinson’s Foundation Centre
of Excellence at King’s College Hospital and King’s College
London. It will be a two-arm randomised controlled trial
(SHAPER-PD-Ballet) to investigate the clinical efficacy of
the intervention in a larger sample (160 participants), graded
by the severity of their Parkinson’s (mild, moderate and
severe). Participants will be randomly allocated to receive
12 weekly ballet classes delivered by a team of ENB-trained
dance artists and musicians, lasting approximately 75 min
and incorporating live music, dance, rhythm and voice. A
comparator group will continue on conventional treatment
regimes. Participants will be followed up for up to 6 months
post-intervention, and those allocated to the comparator
group will be offered participation in the ballet sessions at
the end of the project.
The clinical aspect of the study will, for the first time,
use a range of clinically validated outcome measures,
including the comprehensive version of the Non-Motor
Symptom Scale developed at King’s College Hospital.
Fig. 3 Stroke Odysseys tour performance. Image credit: Rosetta Life.
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Secondary outcome measures include assessments of both
motor and non-motor symptoms, such as cognitive decline,
mood, sleep and pain. Additionally, wearable sensors will
provide an objective measure of the Parkinson’s signs as
well as mobility and balance. Assessment quality will be
checked by a ‘masked/blinded’ rater.
A unique aspect will be that all participants will be
offered participation in a substudy of electrodiagnostic mea-
sures, which will employ transcranial magnetic stimulation
coupled with electroencephalography and electromyography
to investigate the effects of the intervention on neural net-
works and brain activity.
Implementation and economic data will be collected to
assess acceptability, appropriateness and feasibility of the
intervention on a large scale and its potential to be adopted
and sustained as a cost-effective and beneficial adjuvant
therapy. All measurements will be conducted at baseline
(before the start of the intervention), immediately post-
intervention between 3 and 6 months post-intervention to
explore the acute and chronic benefits.
To our knowledge, this is the first randomised con-
trolled trial investigating the effects of ballet dancing on peo-
ple with neurological disorders.
Stroke Odysseys (arts partner: Rosetta Life)
Stroke is a leading cause of disability in the UK and world-
wide, and approximately two-thirds of stroke survivors
leave hospital with disability.39 There are over 1.2 million
stroke survivors in the UK, projected to exceed 2 million
by 2035. Stroke costs the UK an estimated £25.6 million
annually.40 Recent data from the Sentinel Stroke National
Audit Programme shows that nearly 40% of patients
between August and November 2017 left hospital with mod-
erate to severe disability (modified Rankin scale, 3–5).41
Indeed, the transition from hospital to home after a life-
changing event such as a stroke is extremely difficult both
for the individual concerned and for their family, friends
and caregivers. Fragmentation of health services often
means that information provision relating to discharge is
poor, which may also contribute to delays in discharge
from hospital.
Stroke Odysseys, a post-stroke performance arts inter-
vention, has been co-designed by artists and developed by
the organisation Rosetta Life in a unique partnership with
south London stroke communities. It is an intervention
using performance arts to support recovery, agency and well-
being in stroke survivors (Fig. 3). The intervention was ini-
tially developed and funded by King’s and Guy’s and St
Thomas’ Charity and has been delivered in four London
boroughs.13
Stroke Odysseys has three stages – clinical intervention,
community intervention and stroke ambassadors – all of
which will be replicated in this study. During the clinical
intervention, while the patient is in hospital, the sessions
will run for 60 min for groups of 6–8 patients in
neuro-rehabilitation wards. These sessions will be led by a
trained movement artist and a singer, and will involve move-
ment, performance exercises, vocal warm-ups and singing.
Dance practices will be rooted in improvisation, somatic
dance theory and carnival/folk dance. Then, in the commu-
nity stage, patients will be invited to perform their own stor-
ies in a 12-week performance intervention, working with
performance arts towards creating a new perception of
their own identity post-stroke. The performance is based
on skills acquired in movement, music, song and spoken
word, which has not only demonstrated benefits on percep-
tion of disability and cognition, but also aims to manage the
anxiety and depression that affects one-third of stroke survi-
vors.42,43 Finally, in the third stage, participants who com-
plete the community intervention will be invited for
training to become advocates for life after stroke: ‘stroke
ambassadors’. Stroke ambassadors support the running of
the programme in hospitals, assisting artists, recruiting par-
ticipants and performing. Stroke ambassadors also speak at
conferences and at regional stroke association groups and
are members of an integrated performance company that
create performance works to advocate for life after stroke.
The study aims to recruit 75 new ambassadors. The main
aim of the study is to evaluate the implementation, impact
and experiences of a community-based performance arts
programme (Stroke Odysseys for stroke survivors) using
mixed methods (interviews, observations and surveys)
prior to and after each programme stage, and carry out
non-participant observations during the workshops. A series
of implementation measures will be used as well as clinical
outcome measures, including the Oxford Participation and
Activities Questionnaire, a patient-reported outcome meas-
ure that assesses patients experiencing a range of health
conditions. In addition, a health economic evaluation will
be performed to cost the resources used in implementing
the programme, and to evaluate wider service utilisation
and associated costs before and after participants complete
the programme and any changes in their quality of life
profile.
Conclusions
Our ambition is that the SHAPER programme will not only
provide conclusive clinical and mechanistic evidence on the
three studies described above, but also offer an invaluable
resource to shape the future of arts interventions within
the realm of rehabilitation for a range of other mental and
physical health conditions.
SHAPER also presents as a unique opportunity to build
a strong evidence base on the clinical effectiveness, imple-
mentation and mechanisms of arts interventions. Such a
knowledge base will bring arts interventions into main-
stream psychiatric care and put them on an equal footing
with other pharmacological and psychosocial approaches.
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